Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
Completed · Phase 2
Conditions studied: Ovarian Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of dexamethasone plus paclitaxel and gemcitabine in treating patients with platinum-resistant recurrent ovarian cancer.
Key facts
- Study ID
- NCT00003449
- Run by
- University of Southern California
- People needed
- 35
- Starts
- 1998-05-01
- Expected to finish
- 2004-02-01
- Last updated by the study team
- 2014-05-22
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- USC/Norris Comprehensive Cancer Center and Hospital — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.